Table 4. Associations between the cytoplasmic expression of RhoT1, Smad4, p16 and the clinicopathological features.
Variables | RhoT1 expression | Smad4 expression | p16 expression | ||||||
low | high | P value | low | high | P value | low | high | P value | |
Age (years) | |||||||||
<60 | 60 | 29 | 0.922 | 70 | 19 | 0.097 | 70 | 19 | 0.299 |
≧60 | 47 | 26 | 49 | 24 | 56 | 36 | |||
Gender | |||||||||
female | 36 | 24 | 0.660 | 38 | 22 | 0.382 | 48 | 12 | 0.897 |
male | 71 | 31 | 81 | 21 | 78 | 24 | |||
Location | |||||||||
head | 80 | 37 | 0.876 | 88 | 29 | 0.744 | 94 | 23 | 0.468 |
body/rear | 27 | 18 | 31 | 14 | 32 | 13 | |||
Size | |||||||||
<4 | 47 | 27 | 0.324 | 52 | 22 | 0.186 | 59 | 15 | 0.114 |
≧4 | 60 | 28 | 67 | 21 | 57 | 21 | |||
Differentiation | |||||||||
moderate/well | 81 | 45 | 0.278 | 94 | 37 | 0.808 | 102 | 29 | 0.149 |
poor | 21 | 10 | 25 | 6 | 24 | 7 | |||
AJCC stage | |||||||||
stage I | 46 | 34 | 0.191 | 50 | 30 | 0.242 | 56 | 24 | 0.33 |
stage II | 60 | 20 | 68 | 12 | 69 | 11 | |||
stage IV | 1 | 1 | 1 | 1 | 1 | 1 |